# Open-label PK Study of Iron Isomaltoside 1000 (Monofer) Administered by 500 mg IV Injection or 1000 mg IV Infusion to Patients With Inflammatory Bowel Disease

> **NCT01213680** · PHASE1 · COMPLETED · sponsor: **Pharmacosmos A/S** · enrollment: 16 (actual)

## Conditions studied

- Inflammatory Bowel Disease

## Interventions

- **DRUG:** Monofer (iron isomaltoside 1000)
- **DRUG:** Monofer

## Key facts

- **NCT ID:** NCT01213680
- **Lead sponsor:** Pharmacosmos A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2012-08
- **Final completion:** 2012-11
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2013-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01213680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01213680, "Open-label PK Study of Iron Isomaltoside 1000 (Monofer) Administered by 500 mg IV Injection or 1000 mg IV Infusion to Patients With Inflammatory Bowel Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01213680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*